Author

Michael J. Prinsen

Washington University in St. LouisORCID 0000-0001-9699-8474Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Alex MabryiD· 1 shared Alexander W. AleemiD· 1 shared Andrew Lawrence MartiniD· 1 shared Chandrashekhara ManithodyiD· 1 shared Che-Pei KungiD· 1 shared Emily R. BrameliD· 1 shared Eric C. FreemaniD· 1 shared Gabriel William PratheriD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex MabryORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyJournal of Investigative DermatologyPeer-reviewedMay 26, 2025

Cutibacterium adaptation to life on humans provides a novel biomarker of C. acnes infections.

Md Shafiuddin, Wen-chi Huang, Gabriel William Prather…·William H. McCoy

This study characterizes RoxP, a Cutibacterium protein essential for skin colonization and infection, and develops a sensitive ELISA to detect it in human biofluids.

7 citationstop 4%

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 16, 2025

ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis Sensitivity

Che-Pei Kung, Nick Terzich, Ma Xenia G. Ilagan…·Jason D. Weber

This study shows ADAR1 protects TNBC cells from ferroptosis by regulating lipid composition, and identifies cobimetinib as a potential therapeutic agent when combined with ADAR1 loss.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky